Drug Profile
Colorectal cancer vaccine - Immunovo/Pepscan Therapeutics
Latest Information Update: 29 Apr 2021
Price :
$50
*
At a glance
- Originator Pepscan Systems
- Developer Immunovo; Pepscan Therapeutics; VU University Medical Center
- Class Cancer vaccines
- Mechanism of Action Immunostimulants; Vascular endothelial growth factor A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Solid tumours
Most Recent Events
- 29 Apr 2021 Phase-I clinical trials in Solid tumours (Late-stage disease) in Netherlands (IM) (NCT02237638)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Solid tumours (Late-stage disease) in Netherlands (IM, Injection)
- 24 Mar 2009 Preclinical development is ongoing in the Netherlands